These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 23091309)

  • 41. Drug-resistance pattern of Mycobacterium tuberculosis strains from patients with pulmonary and extrapulmonary tuberculosis during 2006 to 2013 in a Korean tertiary medical center.
    Lee HY; Lee J; Lee YS; Kim MY; Lee HK; Lee YM; Shin JH; Ko Y
    Korean J Intern Med; 2015 May; 30(3):325-34. PubMed ID: 25995663
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High risk of drug-resistant tuberculosis when first-line therapy fails in a high HIV prevalence setting.
    Satti H; McLaughlin MM; Seung KJ; Becerra MC; Keshavjee S
    Int J Tuberc Lung Dis; 2013 Jan; 17(1):100-6. PubMed ID: 23232009
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Global trends, regional differences and age distribution for the incidence of HIV and tuberculosis co-infection from 1990 to 2019: results from the global burden of disease study 2019.
    Wang Y; Jing W; Liu J; Liu M
    Infect Dis (Lond); 2022 Nov; 54(11):773-783. PubMed ID: 35801264
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characteristics of pulmonary multidrug-resistant tuberculosis patients in Tigray Region, Ethiopia: A cross-sectional study.
    Welekidan LN; Skjerve E; Dejene TA; Gebremichael MW; Brynildsrud O; Agdestein A; Tessema GT; Tønjum T; Yimer SA
    PLoS One; 2020; 15(8):e0236362. PubMed ID: 32797053
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Minimal diversity of drug-resistant Mycobacterium tuberculosis strains, South Africa.
    Gandhi NR; Brust JC; Moodley P; Weissman D; Heo M; Ning Y; Moll AP; Friedland GH; Sturm AW; Shah NS
    Emerg Infect Dis; 2014 Mar; 20(3):426-33. PubMed ID: 24565645
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tuberculosis and HIV co-infection in Vietnam.
    Trinh QM; Nguyen HL; Do TN; Nguyen VN; Nguyen BH; Nguyen TV; Sintchenko V; Marais BJ
    Int J Infect Dis; 2016 May; 46():56-60. PubMed ID: 27044521
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rapid diagnosis of tuberculosis and multidrug resistance by the microscopic-observation drug-susceptibility assay.
    Shah NS; Moodley P; Babaria P; Moodley S; Ramtahal M; Richardson J; Heysell S; Li X; Moll A; Friedland G; Sturm AW; Gandhi NR
    Am J Respir Crit Care Med; 2011 May; 183(10):1427-33. PubMed ID: 21297071
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A meta-analysis of drug resistant tuberculosis in Sub-Saharan Africa: how strongly associated with previous treatment and HIV co-infection?
    Berhan A; Berhan Y; Yizengaw D
    Ethiop J Health Sci; 2013 Nov; 23(3):271-82. PubMed ID: 24307827
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Multidrug-resistant TB and HIV in Thailand: overlapping, but not independently associated, risk factors.
    Akksilp S; Wattanaamornkiat W; Kittikraisak W; Nateniyom S; Rienthong S; Sirinak C; Ngamlert K; Mankatittham W; Sattayawuthipong W; Sumnapun S; Yamada N; Monkongdee P; Anuwatnonthakate A; Burapat C; Wells CD; Tappero JW; Varma JK
    Southeast Asian J Trop Med Public Health; 2009 Sep; 40(5):1000-14. PubMed ID: 19842383
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tuberculosis risk factors and Mycobacterium tuberculosis transmission among HIV-infected patients in Vietnam.
    Mai TQ; Martinez E; Menon R; Van Anh NT; Hien NT; Lan NH; Giang DC; Hang PT; Thuong PH; Van Huan H; Hoang NP; Nhung NV; Hoa NB; Marais BJ; Sintchenko V
    Tuberculosis (Edinb); 2019 Mar; 115():67-75. PubMed ID: 30948179
    [No Abstract]   [Full Text] [Related]  

  • 51. HIV, multidrug-resistant TB and depressive symptoms: when three conditions collide.
    Das M; Isaakidis P; Van den Bergh R; Kumar AM; Nagaraja SB; Valikayath A; Jha S; Jadhav B; Ladomirska J
    Glob Health Action; 2014; 7():24912. PubMed ID: 25215909
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Highly successful treatment outcome of multidrug-resistant tuberculosis in the Netherlands, 2000-2009.
    van Altena R; de Vries G; Haar CH; de Lange WC; Magis-Escurra C; van den Hof S; van Soolingen D; Boeree MJ; van der Werf TS
    Int J Tuberc Lung Dis; 2015 Apr; 19(4):406-12. PubMed ID: 25859995
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Predictors of cure among HIV co-infected multidrug-resistant TB patients at Sizwe Tropical Disease Hospital Johannesburg, South Africa.
    Umanah TA; Ncayiyana JR; Nyasulu PS
    Trans R Soc Trop Med Hyg; 2015 May; 109(5):340-8. PubMed ID: 25787727
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Outcomes of comprehensive care for children empirically treated for multidrug-resistant tuberculosis in a setting of high HIV prevalence.
    Satti H; McLaughlin MM; Omotayo DB; Keshavjee S; Becerra MC; Mukherjee JS; Seung KJ
    PLoS One; 2012; 7(5):e37114. PubMed ID: 22629356
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Adverse events during treatment of drug-resistant tuberculosis: a comparison between patients with or without human immunodeficiency virus co-infection.
    Sagwa E; Ruswa N; Musasa JP; Mantel-Teeuwisse AK
    Drug Saf; 2013 Nov; 36(11):1087-96. PubMed ID: 23917883
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevalence of Multi-Drug Resistant Tuberculosis among Tuberculosis Patients Attending Chest Clinics in Osun-State, Nigeria.
    Oyedeji GJ; Adeyemo C; Dissou A; Abiodun T; Alli OAT; Onaolapo OJ; Onaolapo AY; Adesiji Y; Olowe OA
    Curr Pharm Biotechnol; 2020; 21(10):939-947. PubMed ID: 32101120
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Multidrug-resistant tuberculosis and risk factors associated with its development: a retrospective study.
    Elmi OS; Hasan H; Abdullah S; Mat Jeab MZ; Bin Alwi Z; Naing NN
    J Infect Dev Ctries; 2015 Oct; 9(10):1076-85. PubMed ID: 26517482
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tuberculosis Treatment Outcome and Drug Resistance in Lambaréné, Gabon: A Prospective Cohort Study.
    Bélard S; Remppis J; Bootsma S; Janssen S; Kombila DU; Beyeme JO; Rossatanga EG; Kokou C; Osbak KK; Obiang Mba RM; Kaba HM; Traoré AN; Ehrhardt J; Bache EB; Flamen A; Rüsch-Gerdes S; Frank M; Adegnika AA; Lell B; Niemann S; Kremsner PG; Loembé MM; Alabi AS; Grobusch MP
    Am J Trop Med Hyg; 2016 Aug; 95(2):472-80. PubMed ID: 27352879
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Outcomes of HIV-infected versus HIV-non-infected patients treated for drug-resistance tuberculosis: Multicenter cohort study.
    Bastard M; Sanchez-Padilla E; du Cros P; Khamraev AK; Parpieva N; Tillyashaykov M; Hayrapetyan A; Kimenye K; Khurkhumal S; Dlamini T; Perez SF; Telnov A; Hewison C; Varaine F; Bonnet M
    PLoS One; 2018; 13(3):e0193491. PubMed ID: 29518098
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Alarming levels of multidrug-resistant tuberculosis in Ukraine: results from the first national survey.
    Pavlenko E; Barbova A; Hovhannesyan A; Tsenilova Z; Slavuckij A; Shcherbak-Verlan B; Zhurilo A; Vitek E; Skenders G; Sela I; Cabibbe AM; Cirillo DM; de Colombani P; Dara M; Dean A; Zignol M; Dadu A
    Int J Tuberc Lung Dis; 2018 Feb; 22(2):197-205. PubMed ID: 29506617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.